Filing Details
- Accession Number:
- 0001055726-21-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-11 16:24:37
- Reporting Period:
- 2021-06-09
- Accepted Time:
- 2021-06-11 16:24:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1259780 | Peter Kies | C/O Inovio Pharmaceuticals, Inc. 6769 Mesa Ridge Road San Diego CA 92121 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-09 | 13,750 | $2.16 | 164,538 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-06-09 | 33,750 | $10.01 | 130,788 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Option | Disposition | 2021-06-09 | 13,750 | $0.00 | 13,750 | $2.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2013-03-14 | 2023-03-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,500 | Indirect | By Spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- These transactions were executed in multiple trades at prices ranging from $10.00 to $10.04, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.